Trademark: 86848704
Word
AJOYA
Status
Dead
Status Code
606
Status Date
Monday, March 4, 2019
Serial Number
86848704
Mark Type
4000
Filing Date
Monday, December 14, 2015
Published for Opposition
Tuesday, May 31, 2016
Abandoned Date
Monday, March 4, 2019

Trademark Owner History
ALLERGAN PHARMACEUTICALS INTERNATIONAL L - 1st New Owner After Publication
Warner Chilcott Company, LLC - Owner At Publication

Classifications
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; Pharmaceuticals, namely, neuroprotective agents; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical preparations for skin care used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatories, anti-infectives, anti-glaucoma eye drops and decongestant formulations; sterile ointments for medical use; ocular wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, skin rejuvenators, rehydrating creams, and lotions for the face and body

Trademark Events
Feb 19, 2020
Assignment Of Ownership Not Updated Automatically
Mar 4, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 4, 2019
Abandonment - No Use Statement Filed
Jul 18, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 16, 2018
Extension 4 Granted
Jul 16, 2018
Extension 4 Filed
Jul 16, 2018
Teas Extension Received
Dec 12, 2017
Notice Of Approval Of Extension Request E-Mailed
Dec 8, 2017
Extension 3 Granted
Dec 8, 2017
Extension 3 Filed
Dec 8, 2017
Teas Extension Received
Jun 28, 2017
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2017
Extension 2 Granted
Jun 13, 2017
Extension 2 Filed
Jun 24, 2017
Case Assigned To Intent To Use Paralegal
Jun 21, 2017
Automatic Update Of Assignment Of Ownership
Jun 13, 2017
Teas Extension Received
Jan 31, 2017
Teas Change Of Correspondence Received
Jan 5, 2017
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2017
Extension 1 Granted
Jan 3, 2017
Extension 1 Filed
Jan 3, 2017
Teas Extension Received
Jul 26, 2016
Noa E-Mailed - Sou Required From Applicant
May 31, 2016
Official Gazette Publication Confirmation E-Mailed
May 31, 2016
Published For Opposition
May 11, 2016
Notification Of Notice Of Publication E-Mailed
Apr 28, 2016
Law Office Publication Review Completed
Apr 21, 2016
Assigned To Lie
Apr 8, 2016
Approved For Pub - Principal Register
Apr 5, 2016
Examiner's Amendment Entered
Apr 5, 2016
Notification Of Examiners Amendment E-Mailed
Apr 5, 2016
Examiners Amendment E-Mailed
Apr 5, 2016
Examiners Amendment -Written
Mar 30, 2016
Assigned To Examiner
Dec 18, 2015
New Application Office Supplied Data Entered In Tram
Dec 17, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24